United States: FDA 2017 Year In Review: Therapeutic Products, Part 2

Mondaq News Alerts-8 hours ago

As alluded to above, FDA inspections of traditional compounders and outsourcing facilities continue be very high priority as the Agency seeks to reform the drug compounding industry under the congressional mandate that is the DQSA. Compliance Director Ashley's year-end presentation (see above) reported that, ...